drugset / Trial / NCT01821274

A 21-Day Topical Safety Study of Diltiazem Hydrochloride Using a Cumulative Irritant Patch Test Design

NCT01821274

Phase 1 Unknown 30 enrolled Ventrus Biosciences, Inc
RandomizedSingle-groupTriple-blindTreatment

Summary

The purpose of the study is to determine whether Diltiazem Hydrochloride 2% Cream will cause irritation to skin on the back of healthy volunteers after repeated application over 21-days.

Timeline

Start
2013-03
Primary completion
2013-07
Completion
2013-09

Drugs

EvaluationDrugModalityDoseRoute
Subject Diltiazem Small molecule 2 % Topical
Subject Diltiazem Small molecule 0.2 g Topical
Comparator Sodium Lauryl Sulfate Small molecule 0.1 % Topical
Comparator Sodium Lauryl Sulfate Small molecule 0.2 ml Topical

Indications